Photo: Close up of researcher using a pippette

Vatelizumab

Vatelizumab is being developed as a treatment for relapsing MS, but the phase 2 trial was terminated early in 2016. We don't yet know the next steps for this treatment.

Current phase of trial: Phase 2

Type of MS: Relapsing MS

Find out more about vatelizumab